Allergy

Published on 21/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2152 times

Allergy

An abnormal immune system may result in:

Paediatric allergy

Allergic diseases which affect children include food allergy, eczema, allergic rhinitis and conjunctivitis, asthma, urticaria, insect sting hypersensitivity and anaphylaxis. The reasons allergic diseases are important are:

Explanations of some of the terms used in ‘allergy’ are listed in Box 15.1.

Mechanisms of allergic disease

Many genes have been linked to the development of allergic disease. Polymorphisms or mutations in these genes lead to a susceptibility to allergy.

Allergic diseases occur when individuals make an abnormal immune response to harmless environmental stimuli, usually proteins. The developing immune system must be ‘sensitised’ to an allergen before an allergic immune response develops. However, sensitisation can be ‘occult’, e.g. sensitisation to egg from exposure to trace quantities of egg in maternal breast milk.

Only a few stimuli account for most allergic disease:

Proteins with an unstable tertiary structure may be rendered non-allergenic by heat degradation or other forms of processing. For example, some children are allergic to raw apples, but can tolerate eating cooked apples.

Allergic immune responses are classified as IgE mediated or non-IgE mediated. IgE-mediated allergic reactions have a characteristic clinical course:

The majority of severe life-threatening allergic reactions are IgE mediated.

Non-IgE-mediated allergic immune responses have a delayed onset of symptoms and more varied clinical course.

Prevention of allergic diseases

Many interventions have been tried to prevent allergic disease, or interrupt the allergic march. These include exclusive breast-feeding for at least 3–4 months (or if not possible, then use of hydrolysed formula instead of standard formula milk) to reduce the risk of eczema and cow’s milk allergy and the use of probiotics for eczema in infancy. Other approaches include altering allergen exposure (avoidance of allergens in early life, or alternatively, exposure to large doses of allergens to induce immune tolerance), prebiotics (non-digestible oligosaccharides naturally present in breast milk), nutritional supplements (e.g. omega-3 fatty acids, vitamin D, antioxidants, trace elements) and medications (e.g. antihistamines, immunotherapy). However, none have been shown, long term, to prevent children from developing allergic diseases.

History and examination

The child and family may not volunteer a history of allergic disease as they have come to consider the symptoms as normal, e.g. the child who coughs most nights or has a blocked nose most of the time may not perceive this as abnormal. As allergic diseases are multisystem, in addition to the signs of individual allergic diseases, examination may reveal:

Growth needs to be checked, especially in those with food allergy, where dietary restrictions or malabsorption can lead to nutritional compromise, and in those treated with high-dose inhaled/nasal/topical corticosteroids.

Management

The individual diseases are managed by general practitioners, general paediatricians or organ-specific specialists, e.g. eczema by dermatologists, asthma by respiratory paediatricians. However, allergic diseases coexist and it is therefore helpful to consider allergy as a systemic disease. The role of paediatric allergists is to identify triggers to avoid, and to manage children with multisystem or severe disease.

Management of specific conditions is described below. In addition, specific allergen immunotherapy can be used for treating allergic rhinitis and conjunctivitis, insect stings, anaphylaxis and asthma. During immunotherapy, solutions of an allergen to which the patient is allergic are injected subcutaneously or administered sublingually on a regular basis for 3–5 years, with the aim of developing immune tolerance. It is highly effective in providing protection for many years. However, it must be carried out under specialist supervision due to the risk of inducing severe allergic reactions (anaphylaxis). Allergen immunotherapy is widely used in the USA and some countries in Europe. Sublingual immunotherapy appears to be safer than subcutaneous injections and is used increasingly. Immunotherapy for food allergy is under investigation but has not yet been shown to be safe for use in clinical practice.

Food allergy and food intolerance

A food allergy occurs when a pathological immune response is mounted against a specific food protein. It is usually IgE mediated, but may be non-IgE mediated. A non-immunological hypersensitivity reaction to a specific food is called food intolerance. An example of each in relation to cow’s milk is shown in Figure 15.3.

Food allergy is usually primary, where children have failed to ever develop immune tolerance to the relevant food. Presentation varies with the agent and the child’s age:

Food allergy can also be secondary, where children initially tolerate a food and then later become allergic to it. Secondary food allergy is usually due to cross-reactivity between proteins present in fresh fruits/vegetables/nuts and those present in pollens, e.g. a child who can eat apples may develop allergy to apples in the future if they develop allergy to birch tree pollen, because the apple and birch pollen share a very similar protein. This is termed the ‘oral allergy syndrome’ or ‘pollen fruit syndrome’. It is very common but generally leads to milder allergic reactions than primary food allergy, often causing an itchy mouth but no systemic symptoms.

Non-IgE food allergy typically occurs hours after ingestion and usually involves the gastrointestinal tract.

Food allergy and intolerance are different from food aversion, where the person refuses the food for psychological or behavioural reasons.

Diagnosis

The most helpful screening tests for IgE-mediated food allergy are skin-prick tests (Fig. 15.4) and measurement of specific IgE antibodies in blood (RAST test). Both tests may yield false-positive results, but the greater the response, the more likely the child is to be allergic. Negative skin test results make IgE-mediated allergy unlikely.

Non-IgE-mediated food allergies are harder to diagnose. Diagnosis relies on clinical history and examination. If indicated, endoscopy and intestinal biopsy may be obtained; the diagnosis is supported by the presence of eosinophilic infiltrates.

For both IgE-mediated and non-IgE-mediated food allergies, the gold standard investigation in cases of doubt is exclusion of the relevant food under a dietitian’s supervision, followed by a double-blind placebo-controlled food challenge. This involves the child being given increasing amounts of the food or placebo, starting with a tiny quantity, until a full portion is reached. The test should be performed in hospital with full resuscitation facilities available, and close monitoring for signs of an allergic reaction.

Management

The management of a food-allergic child involves avoidance of the relevant foods. This can be very difficult as the relevant food(s) may be present in small quantities in many foods and food labels are often unclear. Food labelling in the European Union legally requires common food allergens to be clearly disclosed. Food which is packaged or sold elsewhere may be less closely regulated. The advice of a paediatric dietitian is essential to aid patients avoid foods to which they are allergic and avoid nutritional deficiencies.

In addition, the child and family must be able to manage an allergic attack. Written self-management plans and adequate training are essential. Drug management for mild reactions (no cardiorespiratory symptoms) is with antihistamines. If the child has a severe reaction, treatment is with epinephrine (adrenaline) given intramuscularly by auto-injector (e.g. Epipen or Anapen), which the child or parent should carry with them at all times.

Food allergy to cow’s milk and egg often resolves in early childhood; food allergy to nuts and seafood usually persists through to adulthood.

Allergic rhinitis and conjunctivitis (rhinoconjunctivitis)

This can be atopic (associated with IgE antibodies to common inhalant allergens) or non-atopic. It is an underestimated cause of childhood morbidity. The disease can be classified as intermittent or persistent and mild or severe, although in temperate climates it is often classified as seasonal (related to seasonal grass, weed or tree pollens) and perennial (related to perennial allergens such as house-dust mite and pets). It affects up to 20% of children and can severely disrupt their lives. In addition to its classic presentation of coryza and conjunctivitis, it can also present as ‘cough-variant rhinitis’ due to a post-nasal drip, and as a chronically blocked nose causing sleep disturbance and impaired daytime behaviour and concentration, or with predominant eye symptoms. It is associated with eczema, sinusitis and adenoidal hypertrophy and is closely associated with asthma. Treatment of allergic rhinitis may improve the control of coexistent asthma. Treatment options are listed in Box 15.2.

Urticaria and angioedema

Acute urticaria usually results from exposure to an allergen or a viral infection, which triggers an urticarial skin reaction. It may also involve deeper tissues to produce swelling of the lips and soft tissues around the eyes (angioedema), and even anaphylaxis.

Chronic urticaria (persisting >6 weeks) is usually non-allergic in origin. It results from a local increase in the permeability of capillaries and venules. These changes are dependent on activation of skin mast cells, which contain a range of mediators including histamine. A classification of urticaria is shown in Box 15.3. Treatment is with second-generation non-sedating antihistamines.

Insect sting hypersensitivity

This arises mainly from bee and wasp stings, but also from ant species in the USA, Asia and Australia. The severity of the allergic reaction may be:

Children with a previous mild or moderate reaction are unlikely to develop a severe reaction in the future and the families can be reassured. Those who had a severe reaction should carry an epinephrine (adrenaline) auto-injector, and allergen immunotherapy should be considered.

Share this: